Studies using a mouse model in a high-fat diet (HFD) showed that changes in levels of oxidative stress, impaired glucose disposal, insulin signaling, and obesity development could be reversed by oltipraz, an Nrf2 activator [139]. This evidence concerns the gene NFE2L2 and obesity disorder.